Tartaric acid - paediatric investigation plan

Tartaric acid

Key facts

• Active Substance:
  Tartaric acid
• Therapeutic area:
  Uro-nephrology
• Decision number:
  P/41/2010
• PIP number:
  Tartaric acid
• Pharmaceutical form(s):
  Nebuliser solution
• Condition(s) / indication(s):
  Stress incontinence, female
• Route(s) of administration:
  Inhalation use
• Contact for public enquiries:

  Pneumoflex E.U. Limited

  E-mail: [e-mail]; Country: United Kingdom; Phone: [phone]; Fax: [phone]

• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  31/03/2010

Decision

P/41/2010: European Medicines Agency decision of 31 March 2010 on the granting of a product specific waiver for tartaric acid (EMEA-000772-PIP01-09) in accordance with Regulation (EC) No 1901/2006 of the European Parliam...

Reference Number: EMA/173479/2010